Abstract Details
John A. Hey, PhD
(Alzheon)
PRESENTER |
Dr. Hey has received personal compensation for serving as an employee of Alzheon. Dr. Hey has stock in Alzheon. Dr. Hey has stock in Alzheon. Dr. Hey has received intellectual property interests from a discovery or technology relating to health care. |
Sawsan (Susan) R. Abushakra, MD | Dr. Abushakra has received personal compensation for serving as an employee of Alzheon Inc. Dr. Abushakra has stock in Alzheon Inc. The institution of Dr. Abushakra has received research support from NIA. Dr. Abushakra has received intellectual property interests from a discovery or technology relating to health care. |
Kaj Blennow | No disclosure on file |
Philip Scheltens, MD, PhD, FAAN (Alzheimer Center Amsterdam University medical Center) | Dr. Scheltens has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVO NOrdisk. |
Jakub Hort, MD | Dr. Hort has received personal compensation in the range of $0-$499 for serving as a Consultant for Alzheimerchain. Dr. Hort has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Hort has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Schwabe. Dr. Hort has stock in Alzheon. |
No disclosure on file | |
Niels D. Prins, MD (Brain Research Center) | Dr. Prins has stock in Brain Research Center. Dr. Prins has received personal compensation in the range of $100,000-$499,999 for serving as a CEO with Brain Research Center. |
No disclosure on file | |
Paul L. Dautzenberg, PhD (Jeroen Bosch Ziekenhuis, Depr Geriatrics) | Dr. Dautzenberg has nothing to disclose. |
Ladislav Pazdera, MD, FAAN (Vestra Clinics S.r.o.) | Dr. Pazdera has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Pazdera has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. |
No disclosure on file | |
Rosalind Mandelbaum, PA (Donald S. Marks, M.D., P.C.) | No disclosure on file |
Aidan Power, PhD (Alzheon) | Dr. Power has received personal compensation for serving as an employee of Alzheon. Dr. Power has stock in Pfizer. Dr. Power has stock in Alzheon. |
Martin Tolar, MD, PhD (Alzheon) | Dr. Tolar has received personal compensation for serving as an employee of Alzheon. Dr. Tolar has received intellectual property interests from a discovery or technology relating to health care. |